Premature impairment of methylation pathway and cardiac metabolic dysfunction in fa/fa obese Zucker rats

Journal of Proteome Research

Volumn 12, Issue 4, 2013, Pages 1935-1945

  De Castro, Nuria M ^a   Yaqoob, Parveen ^b   De La Fuente, Mónica ^a   Baeza, Isabel ^a   Claus, Sandrine P ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

aging; metabonomics; obesity; type II diabetes; Zucker rats

Indexed keywords

CHOLINE; CREATINE; PHOSPHORYLCHOLINE;

ABDOMINAL SUBCUTANEOUS FAT; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; GLUCOSE METABOLISM; HEART MUSCLE METABOLISM; HYPERPHAGIA; LIPID METABOLISM; LIVER METABOLISM; MALE; METABOLIC DISORDER; METHYLATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WHITE ADIPOSE TISSUE; ZUCKER RAT;

ADIPOSE TISSUE, WHITE; AGE FACTORS; ANIMALS; BETAINE; DISEASE MODELS, ANIMAL; INOSITOL; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; METHYLATION; MYOCARDIUM; OBESITY; PHOSPHORYLCHOLINE; RATS; RATS, ZUCKER;

ANIMALIA; RATTUS;

EID: 84875950872     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400025y     Document Type: Article

References (66)

1. Arora, S. Anubhuti role of neuropeptides in appetite regulation and obesity-A review Neuropeptides 2006, 40, 375-401
2. Greenberg, A. S.; Obin, M. S. Obesity and the role of adipose tissue in inflammation and metabolism Am. J. Clin. Nutr. 2006, 83, 461S-465S
3. de Ferranti, S.; Mozaffarian, D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences Clin. Chem. 2008, 54, 945-955
4. Gami, A. S.; Witt, B.; Howard, D.; Erwin, P.; Gami, L. A.; Somers, V. K.; Montori, V. M. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies J. Am. Coll. Cardiol. 2007, 49, 403-414
5. Frühbeck, G.; Gómez-Ambrosi, J.; Muruzábal, F. J.; Burrell, M. A. The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation Am. J. Physiol.: Endocrinol. Metab. 2001, 280, E827-E847
6. Wang, P.; Mariman, E.; Renes, J.; Keijer, J. The secretory function of adipocytes in the physiology of white adipose tissue J. Cell. Physiol. 2008, 216, 3-13
7. Zhang, J.; Shi, G.-P. Mast cells and metabolic syndrome Biochim. Biophys. Acta 2012, 1822, 14-20
8. Maury, E.; Brichard, S. M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome Mol. Cell. Endocrinol. 2010, 314, 1-16
9. Srinivasan, K.; Ramarao, P. Animal models in type 2 diabetes research: an overview Indian J. Med. Res. 2007, 125, 451-472
10. Bray, G. A. The Zucker-fatty rat: A review Fed. Proc. 1977, 36, 148-153
11. Aleixandre de Artiñano, A.; Miguel Castro, M. Experimental rat models to study the metabolic syndrome Br. J. Nutr. 2009, 102, 1246-1253
12. Ahima, R. S.; Flier, J. S. Adipose tissue as an endocrine organ Trends Endocrinol. Metab. 2000, 11, 327-332
13. Li, J.; Li, F.; Zhao, A. Inflammation and leptin Drug Discovery Today: Dis. Mech. 2006, 3, 387-393
14. De la Fuente, M.; Baeza, I.; Guayerbas, N.; Puerto, M.; Castillo, C.; Salazar, V.; Ariznavarreta, C.; F-Tresguerres, J. A. Changes with ageing in several leukocyte functions of male and female rats Biogerontology 2004, 5, 389-400
15. Viveros, M.-P.; Arranz, L.; Hernanz, A.; Miquel, J.; De la Fuente, M. A model of premature aging in mice based on altered stress-related behavioral response and immunosenescence Neuroimmunomodulation 2007, 14, 157-162
16. De la Fuente, M.; Miquel, J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging Curr. Pharm. Des. 2009, 15, 3003-3026
17. Serpillon, S.; Floyd, B. C.; Gupte, R. S.; George, S.; Kozicky, M.; Neito, V.; Recchia, F.; Stanley, W.; Wolin, M. S.; Gupte, S. A. Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH Am. J. Physiol.: Heart Circ. Physiol. 2009, 297, H153-62
18. Vincent, H. K.; Powers, S. K.; Stewart, D. J.; Shanely, R. A.; Demirel, H.; Naito, H. Obesity is associated with increased myocardial oxidative stress Int. J. Obes. Relat. Metab. Disord. 1999, 23, 67-74
19. Nicholson, J. K.; Wilson, I. D. Understanding "global" systems biology: Metabonomics and the continuum of metabolism Nat. Rev. Drug Discovery 2003, 2, 668-676
20. Mestdagh, R.; Dumas, M.-E.; Rezzi, S.; Kochhar, S.; Holmes, E.; Claus, S. P.; Nicholson, J. K. Gut microbiota modulate the metabolism of brown adipose tissue in mice J. Proteome Res. 2012, 11, 620-630
21. 1H NMR metabonomic study reveals new triglycerides promoting mechanisms of monoethyl-hexyl phthalate in human adipocytes J. Proteome Res. 2011, 10 (12) 5493-5502
22. Waldram, A.; Holmes, E.; Wang, Y.; Rantalainen, M.; Wilson, I. D.; Tuohy, K. M.; McCartney, A. L.; Gibson, G. R.; Nicholson, J. K. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents J. Proteome Res. 2009, 8, 2361-2375
23. Williams, R. E.; Lenz, E. M.; Rantalainen, M.; Wilson, I. D. The comparative metabonomics of age-related changes in the urinary composition of male Wistar-derived and Zucker (fa/fa) obese rats Mol. BioSyst. 2006, 2, 193-202
24. Aue, W. P. Two-dimensional spectroscopy. Application to nuclear magnetic resonance J. Chem. Phys. 1976, 64, 2229-2246
25. Glaser, S. J.; Schwalbe, H.; Marino, J. P.; Griesinger, C. Directed TOCSY, a method for selection of directed correlations by optimal combinations of isotropic and longitudinal mixing J. Magn. Reson., Ser. B 1996, 112, 160-180
26. Marek, R.; Králík, L.; Sklenář, V. Gradient-enhanced HSQC experiments for phase-sensitive detection of multiple bond interactions Tetrahedron Lett. 1997, 38, 665-668
27. 13C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67, 793-811
28. Fan, T. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures Prog. Nucl. Magn. Reson. Spectrosc. 1996, 28, 161-219
29. Garrod, S.; Humpher, E.; Connor, S. C.; Connelly, J. C.; Spraul, M.; Nicholson, J. K.; Holmes, E. High-resolution (1)H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue Magn. Reson. Med. 2001, 45, 781-790
30. Waters, N. J.; Holmes, E.; Waterfield, C. J.; Farrant, R. D.; Nicholson, J. K. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate Biochem. Pharmacol. 2002, 64, 67-77
31. 13C magic angle spinning NMR spectroscopy of rat liver Magn. Reson. Med. 2000, 44, 201-207
32. 1H NMR spectra for improved metabolic biomarker recovery Anal. Chem. 2009, 81, 56-66
33. 1H NMR metabonomics Anal. Chem. 2006, 78, 4281-4290
34. Cloarec, O. Cross fitted partial least squares (CF-PLS): an alternative algorithm for a more reliable PLS J. Chemom. 2011, 25, 208-215
35. Serkova, N. J.; Jackman, M.; Brown, J. L.; Liu, T.; Hirose, R.; Roberts, J. P.; Maher, J. J.; Niemann, C. U. Metabolic profiling of livers and blood from obese Zucker rats J. Hepatol. 2006, 44, 956-962
36. Satapati, S.; He, T.; Inagaki, T.; Potthoff, M.; Merritt, M. E.; Esser, V.; Mangelsdorf, D. J.; Kliewer, S. A.; Browning, J. D.; Burgess, S. C. Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism Diabetes 2008, 57, 2012-2021
37. Rezzi, S.; Martin, F. P. J.; Shanmuganayagam, D.; Colman, R. J.; Nicholson, J. K.; Weindruch, R. Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates Exp. Gerontol. 2009, 44, 356-362
38. Kim, S. K.; Choi, K. H.; Kim, Y. C. Effect of acute betaine administration on hepatic metabolism of S-amino acids in rats and mice Biochem. Pharmacol. 2003, 65, 1565-1574
39. Kathirvel, E.; Morgan, K.; Nandgiri, G.; Sandoval, B. C.; Caudill, M. A.; Bottiglieri, T.; French, S. W.; Morgan, T. R. Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine Am. J. Physiol.: Gastrointest. Liver Physiol. 2010, 299, G1068-G1077
40. Ratnam, S.; Wijekoon, E. P.; Hall, B.; Garrow, T. A.; Brosnan, M. E.; Brosnan, J. T. Effects of diabetes and insulin on betaine-homocysteine S-methyltransferase expression in rat liver Am. J. Physiol.: Endocrinol. Metab. 2006, 290, E933-E9339
41. Hartz, C. S.; Nieman, K. M.; Jacobs, R. L.; Vance, D. E.; Schalinske, K. L. Hepatic phosphatidylethanolamine N-methyltransferase expression is increased in diabetic rats J. Nutr. 2006, 136, 3005-3009
42. Sundler, R.; Akesson, B. Regulation of phospholipid biosynthesis in isolated rat hepatocytes. Effect of different substrates J. Biol. Chem. 1975, 250, 3359-3367
43. Vance, D. E.; Li, Z.; Jacobs, R. L. Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiology J. Biol. Chem. 2007, 282, 33237-33241
44. Jacobs, R. L.; Stead, L. M.; Devlin, C.; Tabas, I.; Brosnan, M. E.; Brosnan, J. T.; Vance, D. E. Physiological regulation of phospholipid methylation alters plasma homocysteine in mice J. Biol. Chem. 2005, 280, 28299-28305
45. Hoogeveen, E. K.; Kostense, P. J.; Beks, P. J.; Mackaay, A. J.; Jakobs, C.; Bouter, L. M.; Heine, R. J.; Stehouwer, C. D. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study Arterioscler., Thromb., Vasc. Biol. 1998, 18, 133-138
46. Craig, S. A. S. Betaine in human nutrition Am. J. Clin. Nutr. 2004, 80, 539-549
47. Lu, S. C. Regulation of hepatic glutathione synthesis: current concepts and controversies FASEB J. 1999, 13, 1169-1183
48. Deneke, S. M.; Fanburg, B. L. Regulation of cellular glutathione Am. J. Physiol. 1989, 257, L163-L173
49. Yancey, P. H. Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses J. Exp. Biol. 2005, 208, 2819-2830
50. Aruoma, O. I.; Halliwell, B.; Hoey, B. M.; Butler, J. The antioxidant action of taurine, hypotaurine and their metabolic precursors Biochem. J. 1988, 256, 251-255
51. Zwingmann, C.; Bilodeau, M. Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver Hepatology 2006, 43, 454-463
52. Sakuragawa, T.; Hishiki, T.; Ueno, Y.; Ikeda, S.; Soga, T.; Yachie-Kinoshita, A.; Kajimura, M.; Suematsu, M. Hypotaurine is an energy-saving hepatoprotective compound against ischemia-reperfusion injury of the rat liver J. Clin. Biochem. Nutr. 2010, 46, 126-134
53. Kwon, D. Y.; Jung, Y. S.; Kim, S. J.; Park, H. K.; Park, J. H.; Kim, Y. C. Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats J. Nutr. 2009, 139, 63-68
54. Häussinger, D.; Schliess, F. Glutamine metabolism and signaling in the liver Front. Biosci. 2007, 12, 371-391
55. Lopaschuk, G. D.; Ussher, J. R.; Folmes, C. D. L.; Jaswal, J. S.; Stanley, W. C. Myocardial fatty acid metabolism in health and disease Physiol. Rev. 2010, 90, 207-258
56. Chatham, J. C.; Rosiers, Des, C.; Forder, J. R. Evidence of separate pathways for lactate uptake and release by the perfused rat heart Am. J. Physiol.: Endocrinol. Metab. 2001, 281, E794-E802
57. Wallis, J.; Lygate, C. A.; Fischer, A.; Hove, ten, M.; Schneider, J. E.; Sebag-Montefiore, L.; Dawson, D.; Hulbert, K.; Zhang, W.; Zhang, M. H.; Watkins, H.; Clarke, K.; Neubauer, S. Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: Insights from creatine transporter-overexpressing transgenic mice Circulation 2005, 112, 3131-3139
58. Phillips, D.; Hove, ten, M.; Schneider, J. E.; Wu, C. O.; Sebag-Montefiore, L.; Aponte, A. M.; Lygate, C. A.; Wallis, J.; Clarke, K.; Watkins, H.; Balaban, R. S.; Neubauer, S. Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity J. Mol. Cell. Cardiol. 2010, 48, 582-590
59. Vasan, R. S. Cardiac function and obesity Heart 2003, 89, 1127-1129
60. Rossi, A.; Olivares, J. Basis of pyrimidine nucleotide metabolism in the myocardium Cardiovasc. Drugs Ther. 1998, 12 (Suppl 2) 171-177
61. Panagia, V.; Taira, Y.; Ganguly, P. K.; Tung, S.; Dhalla, N. S. Alterations in phospholipid N-methylation of cardiac subcellular membranes due to experimentally induced diabetes in rats J. Clin. Invest. 1990, 86, 777-784
62. Huxtable, R. J. Physiological actions of taurine Physiol. Rev. 1992, 72, 101-163
63. Hayes, K. C.; Sturman, J. A. Taurine in metabolism Annu. Rev. Nutr. 1981, 1, 401-425
64. Schaffer, S. W.; Jong, C. J.; Ramila, K. C.; Azuma, J. Physiological roles of taurine in heart and muscle J. Biomed. Sci. 2010, 17 (Suppl. 1) S2
65. Jones, G. L. A. H.; Sang, E.; Goddard, C.; Mortishire-Smith, R. J.; Sweatman, B. C.; Haselden, J. N.; Davies, K.; Grace, A. A.; Clarke, K.; Griffin, J. L. A functional analysis of mouse models of cardiac disease through metabolic profiling J. Biol. Chem. 2004, 280, 7530-7539
66. Arai, Y.; Takayama, M.; Abe, Y.; Hirose, N. Adipokines and aging J. Atheroscler. Thromb. 2011, 18, 545-550